Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2005

View Archived Issues

Evidence suggests oxidized phospholipids may increase the risk of coronary artery disease

Genzyme reviews pipeline progress through quarter

ImaRx Therapeutics receives SBIR grant for targeted nanobubble development

CytoGenix and Aldevron collaborate on DNA vaccine technology

Lilly reports phase III results for ruboxistaurin mesilate

Phase III Flurizan trial enrolling on schedule

Imvamune protects against monkeypox in vivo

Good safety profile reported for GTI-2040 in advanced cancer

Quetiapine improves depression in patients with bipolar disorder

Phase I data on the safety profile of CTA-018 in patients with plaque psoriasis

Promising phase III data shows ISA-247 is safe and effective in plaque psoriasis

Prasugrel decreases the incidence of cardiac events in patients undergoing PCI

Oncotherapy Science and ConGenex to develop anticancer compounds

Japanese conditions for approval of Remicade relaxed

Gene therapy targeting survivin reverses PAH

Kissei launches thromboxane synthetase inhibitor Xanbon S in Japan

Diovan approved for high-risk heart attack survivors

Novel antiinfective agents reported in recent patents

New agents for cardiovascular diseases in early development

New potential cancer treatments disclosed in patent literature

Withdrawal of Infanrix HepB marketing authorization in Europe

Selective serotonin 5-HT6 antagonists improve memory formation in rats

Novel antihyperglycemic agent reduces hepatic glucose production

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...